Dinos Paul Santafianos

Title: Dinos Paul Santafianos: Innovator in Pharmaceutical Chemistry

Introduction

Dinos Paul Santafianos is a notable inventor based in Manchester, CT (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for treating hyperproliferative disorders, including cancer. With a total of 2 patents, his work has the potential to impact the medical community significantly.

Latest Patents

Santafianos' latest patents include the following:

1. **N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate** - This invention relates to the anhydrous and hydrate forms of the compound. It also encompasses pharmaceutical compositions containing this compound and methods for treating hyperproliferative disorders, such as cancer, through its administration.

2. **N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate** - Similar to the first patent, this invention also pertains to the anhydrous and hydrate forms of the compound, along with its pharmaceutical applications and treatment methods for hyperproliferative disorders.

Career Highlights

Throughout his career, Dinos Paul Santafianos has worked with prominent companies in the pharmaceutical industry, including Osi Pharmaceuticals, Inc. and Pfizer Products Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Some of his notable coworkers include Douglas John Meldrum Allen and Timothy Norris. Their collaborative efforts have likely played a role in advancing the research and development of pharmaceutical solutions.

Conclusion

Dinos Paul Santafianos is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in treating serious medical conditions. His contributions through patents and collaborations highlight his commitment to innovation in the field.